PAREXEL - Early Phase Unit — Glendale, California

PAREXEL - Early Phase Unit is a clinical research site located in Glendale, California, United States 91206.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

PAREXEL - Early Phase Unit has participated in 1 clinical trials.

Therapeutic areas: Healthy Subjects, Pharmacokinetics of ASP015K.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PAREXEL - Early Phase Unit?

PAREXEL - Early Phase Unit has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PAREXEL - Early Phase Unit conducted?

PAREXEL - Early Phase Unit has 1 clinical trials on record. Their work covers Healthy Subjects, Pharmacokinetics of ASP015K.

Is PAREXEL - Early Phase Unit accredited by Crixeo Health?

PAREXEL - Early Phase Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PAREXEL - Early Phase Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.